drugset / Trial / NCT05036421

Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin

NCT05036421

Phase 3 Completed 18 enrolled Ain Shams University
NaSingle-groupOpen-labelOther

Summary

The aim of this works is to investigate the effect of genetic polymorphism of snps on human response to treatment with empagliflozin and its correlation with with pharmacokinetic parameters in Egyptian subjects

Timeline

Start
2022-02-15
Primary completion
2022-05-20
Completion
2022-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule 10 mg Oral